A Terah, Portuguese startup founded in October 2022, is preparing for a significant expansion in Brazil with the support of FHE Ventures, que promete acelerar o crecimiento de la empresa en el país. The innovative company developed a unique worldwide solution for comprehensive medication management and consumer guidance through interactive and digitized leaflets, raising the question about the existence of paper leaflets, que aumentam o tamanho e peso da caixa e, therefore, the cost of the medication, além de ser um poluente após o descarte da caixa e do medicamento. Além do apoio à expansão no Brasil, FHE Ventures also contributes to the structuring of the company in Portugal, and not only supports and strengthens the Terah team's experience, as well as optimises businesses by exploring new commercial horizons.
Both parties have high expectations for this partnership. FHE Ventures will be fundamental in the growth process of Terah, providingknow-howand experience for product maturation. Furthermore, the commercial knowledge of FHE Ventures will be vital to conquer the market, with access to major pharmaceutical companies and pharmacy chains in Brazil, highlights Rafael Kenji, CEO da FHE Ventures.
Terah is the first comprehensive global solution for 360° medication management. The application allows users to receive detailed information, schedule reminders and receive alerts. Uma startup identifica possíveis interações medicamentosas e permite a realização de encomendas diretamente com as farmácias. Thecore businessda Terah está nas funcionalidades oferecidas ao utilizador final, with pharmacies as paying clients through a fee on orders. The initial objectives include optimizing the product, increase its robustness and improve performance, assim como concretizar o plano de expansão. The strategy involves implementing a pilot project in a designated region, with the aim of eventually covering the entire Brazilian territory, João Mota, CEO da Terah.
The company is already working to implement its first round of investments. In the advanced stage of acceleration in Brazil, the company believes it is the ideal time to start raising funds. So far, more than 150 thousand euros have already been invested, the equivalent of R$ 800 thousand, no desenvolvimento da solução. By the end of 2024, Terah expects to be close to 100,000 users and have around 5,000 associated pharmacies. Currently, a startup has already established partnerships with around 450 pharmacies in Portugal.
Terah stands out for offering end-to-end medication management, with features that go far beyond a simple alarm. The application allows the reading of medication codes, providing detailed information, identifying drug interactions and therapeutic duplications, besides making it easier to order medicines directly from pharmacies, João Mota has finished.
